ADHD in the News 2026-08-06
OHSU study identifies link between caregiver-child relationship, ADHD symptoms
Research builds on findings that inflammation during pregnancy increases risk of ADHD, highlights need to support early sensitive caregiving
Birth order may influence your disease risk later in life, study finds
Whether you are first-born or second-born may be associated with your risk of developing certain diseases, according to a new study published in Nature Health.
6 questions to ask before you inherit an adult ADHD stimulant prescription
The patient in front of you was diagnosed during a 20-minute telehealth visit, has been taking stimulants for 8 months, and just transferred care to your practice. The refill request is sitting in your inbox. Do you sign it?
The Dopamine Hit of an A.D.H.D. Label (Opinion)
Why are so many people embracing diagnostic labels online? Mary H.K. Choi, who has written about her own A.D.H.D. and autism, argues that naming our struggles offers something powerful: the feeling that they’re finally understood — and even solved.
Have We Turned Personality Into Diagnosis? (Opinion)
Influencers on social media are sharing content that claims to help followers self-diagnose complex medical conditions ranging from A.D.H.D. to autism. And the data reveals that the effect of self-diagnosis is far-reaching. But what happens when large portions of the population believe they have a condition that medical data doesn’t back up? On “The Opinions,” the culture editor Nadja Spiegelman speaks with the columnist and sociologist Tressie McMillan Cottom and the author Mary H.K. Choi — who has written about her own A.D.H.D. and autism — about the phenomenon of self diagnosis, the need for people to label themselves and whether such labels can help or limit us.
When Debate Becomes Denial: Why Channel 4’s ADHD Framing Matters
Jenny, Amnesty's Disabled People's Human Rights Network Committee member, responds to the language used to promote Channel 4's documentary 'The Great ADHD Myth?'
Why are South Asian children being underdiagnosed with autism and ADHD?
Westbourne Primary seems like any other school from the outside. But for a small number of its students, the morning lessons look different. These children make up the school’s extra provision class - a bespoke session designed for pupils who are suspected of having special educational needs. Of the 13 students in the group, ten are South Asian, and four of these are undiagnosed.
The “ADHD advantage” in entrepreneurship applies mostly to intelligent men, study finds
A recent study published in Applied Psychology suggests that attention-deficit hyperactivity disorder (ADHD) is associated with a higher likelihood of becoming an entrepreneur, but only for highly intelligent men. For women with the condition, the opposite tends to be true, with ADHD linked to the lowest rates of business ownership regardless of cognitive ability. These findings provide evidence that the professional advantages sometimes associated with neurodiversity heavily depend on an individual’s gender and intelligence.
Neurodiversity linked to violence-related emergency department visits
People with ADHD are more likely to experience violence and attend hospital Emergency Departments, finds new research by Cardiff University, Swansea University and the University of York. The work is published in Emergency Medicine Journal.
ADHD medication helps children focus by stabilizing brain networks, new study suggests
A small study shows that a common medication for attention deficit hyperactivity disorder helps children focus by stabilizing how different brain regions communicate with one another. The research, published in Translational Psychiatry, suggests that this brain stabilization is tied directly to better attention and task performance.
First UK specific ADHD toolkit now available to primary schools
A new ADHD toolkit from the University of Exeter is the first of its kind designed specifically to be used in UK primary schools.
Centanafadine in ADHD: Clinical Significance of the First Triple Reuptake Inhibitor for ADHD
New ADHD option Simtriyo gains FDA approval as first NDSRI, showing benefits for teens and adults, including executive function and emotional control.